Topic Editors

IBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal
IBB—Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1, 1049-001 Lisbon, Portugal

Antimicrobial Agents and Nanomaterials

Abstract submission deadline
closed (30 April 2024)
Manuscript submission deadline
30 September 2024
Viewed by
56830

Topic Information

Dear Colleagues,

Antimicrobial resistance (AMR) has come to represent a major problem that is attested across healthcare settings worldwide. AMR is caused by multidrug-resistant (MDR) microorganisms, or “superbugs”, which can evade many of the antibiotics used in clinical practice. Today, MDR microorganisms constitute a great clinical and economic burden. In fact, the current methods of clinical treatment have started to rely on more aggressive antibiotic therapy, leading to a decrease in the life quality of the infected patients and an increase in the associated therapeutic costs. Due to the failure of conventional antibiotics, we are now entering a new era of clinical treatment based on compounds. This is reflected, for example, in the development of antibacterial nanomaterials or nanoantibiotics. This Topic collection aims to identify novel strategies that may be used to overcome AMR, with a particular focus on the development of medical nanomaterials. Topics of interest include, but are not limited to, the following:

  • Antimicrobial polymers;
  • Antimicrobial peptides and peptidomimetics;
  • Synergic effects of antimicrobial agents;
  • Antimicrobial coatings;
  • Inhibitors of virulence factors;
  • Drug nanodelivery systems;

We welcome the contributions of authors working in this critical field of research.

Dr. Sandra Pinto
Prof. Dr. Vasco D. B. Bonifácio
Topic Editors

Keywords

  • multidrug resistant bacteria (MDR)
  • resistance mechanisms
  • antibiotics
  • novel antimicrobial agents
  • drug susceptibility

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Molecules
molecules
4.2 7.4 1996 15.1 Days CHF 2700 Submit
Pharmaceutics
pharmaceutics
4.9 7.9 2009 14.9 Days CHF 2900 Submit
Antibiotics
antibiotics
4.3 7.3 2012 14.7 Days CHF 2900 Submit
Microorganisms
microorganisms
4.1 7.4 2013 13.4 Days CHF 2700 Submit
Biomolecules
biomolecules
4.8 9.4 2011 16.3 Days CHF 2700 Submit
Marine Drugs
marinedrugs
4.9 9.6 2003 12.9 Days CHF 2900 Submit
Polymers
polymers
4.7 8.0 2009 14.5 Days CHF 2700 Submit
International Journal of Molecular Sciences
ijms
4.9 8.1 2000 18.1 Days CHF 2900 Submit

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (32 papers)

Back to TopTop